v1
Faculty Opinions recommendation of Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study.
NobleIDNI1P28W13R47S56
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260521/BCB2ABBD)
ARK Inflections
Metadata Formats
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims
Paper Authors